Menu
GeneBe

CLEC4A

C-type lectin domain family 4 member A, the group of C-type lectin domain containing|CD molecules

Basic information

Region (hg38): 12:8123616-8138607

Previous symbols: [ "CLECSF6" ]

Links

ENSG00000111729NCBI:50856OMIM:605306HGNC:13257Uniprot:Q9UMR7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CLEC4A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLEC4A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
13
clinvar
2
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 2 0

Variants in CLEC4A

This is a list of pathogenic ClinVar variants found in the CLEC4A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-8123886-C-T not specified Uncertain significance (Dec 02, 2022)2331963
12-8123939-A-T not specified Uncertain significance (May 28, 2024)3267687
12-8123940-T-C not specified Likely benign (Jun 10, 2024)3267689
12-8129314-C-A not specified Uncertain significance (Mar 31, 2024)3267690
12-8129339-T-C not specified Uncertain significance (May 01, 2022)2286864
12-8129356-G-A not specified Likely benign (Oct 05, 2023)3145662
12-8135588-C-T not specified Uncertain significance (Oct 05, 2022)2389366
12-8135596-A-T not specified Uncertain significance (Dec 09, 2023)3145663
12-8136830-G-A not specified Uncertain significance (Apr 05, 2023)2512347
12-8136858-G-A not specified Uncertain significance (Sep 25, 2023)3145664
12-8138153-C-T not specified Uncertain significance (May 26, 2024)2364398
12-8138154-G-A not specified Likely benign (Mar 28, 2024)3267688
12-8138162-A-T not specified Uncertain significance (May 15, 2023)2546143
12-8138163-G-A not specified Likely benign (May 15, 2023)2521086
12-8138177-C-T not specified Uncertain significance (Nov 18, 2022)2411542
12-8138198-C-T not specified Uncertain significance (Aug 26, 2022)2309191
12-8138220-G-A not specified Uncertain significance (Nov 10, 2022)2206404
12-8138246-C-T not specified Uncertain significance (Oct 29, 2021)2258198
12-8138250-A-C not specified Uncertain significance (Feb 23, 2023)2462432
12-8138264-G-A not specified Likely benign (Mar 28, 2024)3267691
12-8138285-T-C Benign (Dec 31, 2019)732592

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CLEC4Aprotein_codingprotein_codingENST00000229332 614976
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004190.6441257140331257470.000131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5451071240.8620.000006201571
Missense in Polyphen2528.0520.89121396
Synonymous-0.4844843.91.090.00000223418
Loss of Function0.849811.00.7245.65e-7135

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006070.000607
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001230.000123
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: C-type lectin receptor that binds carbohydrates mannose and fucose but also weakly interacts with N-acetylglucosamine (GlcNAc) in a Ca(2+)-dependent manner (PubMed:27015765). Involved in regulating immune reactivity (PubMed:18258799, PubMed:10438934). Once triggered by antigen, it is internalized by clathrin-dependent endocytosis and delivers its antigenic cargo into the antigen presentation pathway resulting in cross-priming of CD8(+) T cells. This cross-presentation and cross-priming are enhanced by TLR7 and TLR8 agonists with increased expansion of the CD8(+) T cells, high production of IFNG and TNF with reduced levels of IL4, IL5 and IL13 (PubMed:18258799, PubMed:20530286). In plasmacytoid dendritic cells, inhibits TLR9-mediated IFNA and TNF production (PubMed:18258799). May be involved via its ITIM motif (immunoreceptor tyrosine-based inhibitory motifs) in the inhibition of B-cell-receptor-mediated calcium mobilization and protein tyrosine phosphorylation (PubMed:10438934). {ECO:0000269|PubMed:10438934, ECO:0000269|PubMed:18258799, ECO:0000269|PubMed:20530286, ECO:0000269|PubMed:27015765}.;
Pathway
Dectin-2 family;C-type lectin receptors (CLRs);Innate Immune System;Immune System (Consensus)

Recessive Scores

pRec
0.0810

Intolerance Scores

loftool
0.991
rvis_EVS
0.71
rvis_percentile_EVS
85.53

Haploinsufficiency Scores

pHI
0.0237
hipred
N
hipred_score
0.112
ghis
0.396

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.144

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Clec4a2
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; hematopoietic system phenotype; digestive/alimentary phenotype; skeleton phenotype; immune system phenotype;

Gene ontology

Biological process
negative regulation of cytokine production;stimulatory C-type lectin receptor signaling pathway;adaptive immune response;plasmacytoid dendritic cell antigen processing and presentation;cell adhesion;cell surface receptor signaling pathway;negative regulation of tumor necrosis factor production;CD8-positive, alpha-beta T cell activation;antigen processing and presentation of exogenous peptide antigen via MHC class I;innate immune response
Cellular component
plasma membrane;integral component of plasma membrane
Molecular function
transmembrane signaling receptor activity;calcium ion binding;mannose binding;carbohydrate binding